Literature DB >> 27345792

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.

Alisa Tubsuwan1, Carlota Pires2, Mikkel A Rasmussen3, Benjamin Schmid3, Jørgen E Nielsen4, Lena E Hjermind4, Vanessa Hall2, Troels T Nielsen4, Gunhild Waldemar4, Poul Hyttel2, Christian Clausen3, Narisorn Kitiyanant1, Kristine K Freude2, Bjørn Holst3.   

Abstract

Induced pluripotent stem cells (iPSCs) were generated from skin fibroblasts isolated from a 58-year old male with a L150P mutation in the presenilin 1 (PSEN-1) gene, which is responsible for the majority of familial cases of Alzheimer's disease (AD). The iPSCs were established by co-electroporation with episomal plasmids containing hOCT4, hSOX2, hL-MYC, hKLF4, hNANOG, hLIN28, and short hairpin RNA against TP53. The iPSCs contained the specific heterozygous mutation c.449C>T, had normal karyotype, expressed the expected pluripotency genes and displayed in vitro differentiation potential to the three germ layers. The iPSCs may be useful for studying familial AD pathology in vitro.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27345792     DOI: 10.1016/j.scr.2015.12.015

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  7 in total

Review 1.  Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.

Authors:  Fernanda Majolo; Daniel Rodrigo Marinowic; Denise Cantarelli Machado; Jaderson Costa Da Costa
Journal:  J Biomed Sci       Date:  2019-02-06       Impact factor: 8.410

2.  Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

3.  Current status and future prospects of stem cell therapy in Alzheimer's disease.

Authors:  Fu-Qiang Zhang; Jin-Lan Jiang; Jing-Tian Zhang; Han Niu; Xue-Qi Fu; Lin-Lin Zeng
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

4.  A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.

Authors:  Joseph Park; Isaac Wetzel; Ian Marriott; Didier Dréau; Carla D'Avanzo; Doo Yeon Kim; Rudolph E Tanzi; Hansang Cho
Journal:  Nat Neurosci       Date:  2018-06-27       Impact factor: 24.884

5.  Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.

Authors:  Anna Ochalek; Balázs Mihalik; Hasan X Avci; Abinaya Chandrasekaran; Annamária Téglási; István Bock; Maria Lo Giudice; Zsuzsanna Táncos; Kinga Molnár; Lajos László; Jørgen E Nielsen; Bjørn Holst; Kristine Freude; Poul Hyttel; Julianna Kobolák; András Dinnyés
Journal:  Alzheimers Res Ther       Date:  2017-12-01       Impact factor: 6.982

6.  Live-Cell Imaging of Single Neurotrophin Receptor Molecules on Human Neurons in Alzheimer's Disease.

Authors:  Klaudia Barabás; Julianna Kobolák; Soma Godó; Tamás Kovács; Dávid Ernszt; Miklós Kecskés; Csaba Varga; Tibor Z Jánosi; Takahiro Fujiwara; Akihiro Kusumi; Annamária Téglási; András Dinnyés; István M Ábrahám
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

7.  Neuronal α-amylase is important for neuronal activity and glycogenolysis and reduces in presence of amyloid beta pathology.

Authors:  Elin Byman; Isak Martinsson; Henriette Haukedal; Gunnar Gouras; Kristine K Freude; Malin Wennström
Journal:  Aging Cell       Date:  2021-07-14       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.